From a molecular medicine standpoint, Relafen 750 ( Naproxen Sodium ) presents a fascinating case study in therapeutic action. Its mechanism of function primarily involves the blockade of cyclooxygenase ( COX mediators) enzymes, particularly COX-II , leading to a reduction in the synthesis of prostaglandins . This selective inhibition accounts for